The FDA has given clearance to an investigational new drug application for TMP-301, a treatment for cocaine use disorders, according to the drug manufacturer.
The program has also been awarded a grant expected to total $5.3 million grant over the course of 2 years from the National Institute on Drug Abuse in support of the development of TMP-301, according to a press release from Tempero Bio.
/PRNewswire/ Tempero Bio has recently been awarded a grant expected to total $5.3 million over two years from the National Institute on Drug Abuse (NIDA),.